2-65071481-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015147.3(CEP68):c.385G>A(p.Glu129Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000382 in 1,613,964 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015147.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP68 | NM_015147.3 | c.385G>A | p.Glu129Lys | missense_variant | 3/7 | ENST00000377990.7 | NP_055962.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP68 | ENST00000377990.7 | c.385G>A | p.Glu129Lys | missense_variant | 3/7 | 1 | NM_015147.3 | ENSP00000367229 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000239 AC: 60AN: 251188Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135742
GnomAD4 exome AF: 0.000408 AC: 596AN: 1461746Hom.: 1 Cov.: 30 AF XY: 0.000408 AC XY: 297AN XY: 727154
GnomAD4 genome AF: 0.000138 AC: 21AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2022 | The c.385G>A (p.E129K) alteration is located in exon 3 (coding exon 2) of the CEP68 gene. This alteration results from a G to A substitution at nucleotide position 385, causing the glutamic acid (E) at amino acid position 129 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at